ChiCTR2400087355
尚未开始
/
/
/
2024-07-25
/
/
精神健康問題及神經認知症
寓樂於思 - 針對患有認知障礙症的抑鬱長者的結構化認知訓練計劃
寓樂於思 - 針對患有認知障礙症的抑鬱長者的結構化認知訓練計劃
In the current proposal, we aim to expand and explore this non-invasive perspective into early intervention for depression in older adults with dementia. We hope to refine the contents of the cognitive training (ACTIVE MIND FOR JOY) to fit the cognitive capacity of depressed clients with mild to moderate cognitive impairment and evaluate if the adaptive program is effective in alleviating depressive symptoms in older adults suffering from dementia.
随机平行对照
Ⅰ期
無
None
林文德慈善基金有限公司
/
70
/
2023-06-01
2024-12-31
/
1) A primary diagnosis of major neurocognitive disorder dementia based on the DSM-5 criteria, with moderate depressive symptoms (Cornell Depression Scale for Dementia >=7) 2) Clinical Dementia rating of 0.5, 1 or 2 indicating mild to moderate cognitive impairment；
请登录查看1) Those who have active suicidal idea, or treatment-resistant [history of electroconvulsive therapy, transcranial magnetic stimulation, or no clinical response to ≥2 different classes of antidepressants] 2) Comorbid personality disorder, functional psychotic disorders, having history of major traumatic brain injury 3) Mentally incompetent to consent for participation in the study 4) Unable to communicate with major sensory deficits；
请登录查看香港中文大學
/
标新生物GLUETACS2025-12-12
兽药资讯2025-12-12
医麦创新药2025-12-12
求实药社2025-12-12
卫材中国2025-12-12
药时空2025-12-12
Being科学2025-12-12
康华股份2025-12-12
康臣药业2025-12-12
汉康生技2025-12-12
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
